目的探究中西医结合疗法用于中晚期肺癌治疗的临床效果。方法选取2009年3月~2012年3月收治入我院的中晚期肺癌患者84例，并将其按照治疗方法分为两组，对照组42患者应用NC方案（长春瑞宾和卡铂）进行化疗，而观察组42例患者在使用NC方案化疗的同时，加服消积逐瘀、益气养血的中药进行治疗，比较两组的临床疗效和不良反应发生情况。结果对照组患者中完全缓解（CR）者6例，部分缓解（PR）者8例，总缓解率为33.33%，观察组患者中完全缓解者9例，部分缓解者13例，总缓解率为52.38%，且两组间比较差异有统计学意义（P＜0.05）；对照组不良反应发生率明显高于观察组（P＜0.05）。结论中药配合西药治疗中晚期肺癌，不仅可以增强临床疗效，同时还有助于减轻副作用与不良反应，值得推广应用。%Objective To explore clinical effect of integrative therapies for advanced lung cancer treatment. Methods A total of 84 patients with gastric cancer that admitted to our hospital during March 2009 and March 2012 were divided into 2 groups randomly. 42 patients of the control group were only applied to the NC program (vinorelbine and carboplatin) chemotherapy, while the experimental group of 42 patients was added to Chinese medicine that replenishing qi and blood,removing blood stasis and eliminating mass and applied to the NC chemotherapy at the same time. The clinical efficacy and incidence of adverse events for them were compared. Results Complete remission (CR) in control group was 6 patients,partial remission (PR) was 8 patients,and the overall response rate was 33.33%;complete remission was 9 patients in the observation group,partial remission(PR) was 13 patients,and the overall response rate was 52.38%. The comparison between the two groups was statistically significant (P < 0.05). The incidence of adverse reactions of the control group was significantly higher than the observation group(P < 0.05). Conclusion The traditional Chinese medicine with western medicine treatment of advanced lung cancer can not only enhance the clinical efficacy,but also help to reduce the side effects and adverse reactions,which should be widely applied.
展开▼
